MedTrace Logo

Cardiac Magnetic Resonance Guidance of Implantable Cardioverter Defibrillator Implantation in Non-ischemic Dilated Cardiomyopathy

NCT04558723 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 760

Last updated 2024-05-13

No results posted yet for this study

Summary

Patients with diagnostic CMR images for assessment of LGE/fibrosis and evidence/presence of non-ischaemic myocardial fibrosis/scar will be randomized to the following treatment groups in a 1:1 ratio: ICD group or Optimal HF care group.

Conditions

  • Non-ischemic Dilated Cardiomyopathy

Interventions

OTHER

ICD/CRT-D implantation

ICD/CRT-D implantation (if indicated)

Sponsors & Collaborators

  • Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

    collaborator OTHER

  • Prof. Dr. med. Ingo Eitel

    lead OTHER

Principal Investigators

  • Ingo Eitel, Prof. Dr. · Medical Clinic II - University Heart Center Lübeck

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-14
Primary Completion
2027-11-30
Completion
2027-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04558723 on ClinicalTrials.gov